http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Jaskirat Singh (검색결과 2 건)
- 무료
- 기관 내 무료
- 유료
-
Chanchal Gautam(Chanchal Gautam ),Jaskirat Kaur(Jaskirat Kaur ),Harpreet Singh(Harpreet Singh ) 사피엔시아 2020 Exercise Medicine Vol.4 No.-
Objectives: Spinal cord injuries lead to impairment of the respiratory system due to paresis or paralysis of the respiratory muscles leading to respiratory insufficiency, which is dependent on the level and completeness of the injury. The aim of this study was to evaluate the effect of upper limb proprioceptive neuromuscular facilitation (PNF) combined with resistance training on respiratory muscle strength and perceived difficulty of breathing in individuals with tetraplegia. Methods: 26 participants with traumatic tetraplegia C5-C8 participated in the study. They were then allocated in two different groups. PNF Group received upper extremity PNF combined with resistance training for 10 repetitions per set, 3 sets 3 times a week for 4 weeks, and CONT Group received respiratory training with triflow type incentive spirometer. Participants were evaluated for maximum inspiratory pressure (MIP), maximum expiratory pressure (MEP) and modified borg scale (MBS). Results: After four weeks of intervention, there were significant improvement in the scores of MIP, MEP, MBS in both groups separately. Also between group comparison showed significant improvement in scores of MIP (P=0.004), MEP (P =0.004), MBS (P=0.001) in PNF Group as compared to CONT Group. Conclusions: This study concludes that there was significant improvement in respiratory muscle strength and rate of perceived difficulty of breathing using upper limb PNF combined with resistance training in tetraplegics.
-
Prospective F-18 FDOPA PET Imaging Study in Human PD
Vijay Dhawan,Martin H Niethammer,Martin L Lesser,Karalyn N Pappas,Matthew Hellman,Toni M Fitzpatrick,David Bjelke,Jaskirat Singh,Loreta M Quatarolo,Yoon Young Choi,Alice Oh,David Eidelberg,Thomas Chal 대한핵의학회 2022 핵의학 분자영상 Vol.56 No.3
Purpose We present the findings of our final prospective study submitted to the U.S. Food and Drug Administration (FDA) for New Drug Application (NDA) approval for the use of 3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine (F-18 FDOPA) positron emission tomography (PET) imaging for Parkinson’s disease (PD). The primary aim was to determine the sensitivity, specificity, and predictive values of F-18 FDOPA PET in parkinsonian patients with respect to clinical standard-oftruth (SOT). Secondary outcomes included the inter-rater reliability, and correlation of quantitative measures for PET with dopaminergic status. Methods In 68 parkinsonian subjects, F-18 FDOPA PET scan from 80 to 100 min was acquired following a CT scan. Scan images were presented to one expert in F-18 FDOPA image interpretation and two physicians with prior experience in I-123 FPCIT single-photon emission computed tomography image interpretation. Fifty-six subjects completed the study with a followup for SOT determination. Image readers were blind to the clinical/quantitative data; SOT clinician was blind to the image data. Results For 47 of the 56 patients, SOT was in agreement with the PET scan results. For nine patients, SOT suggested dopaminergic deficit, whereas the imaging showed normal uptake. The specificity and positive predictive values are 91% and 92%, respectively, suggesting high probability that those who test positive by the PET scan truly have dopaminergic degeneration. The sensitivity was 73%. Inter-rater agreement was 0.6–0.8 between the different readers. Conclusion Our prospective study demonstrates high specificity and moderate sensitivity of F-18 FDOPA PET for PD. We received NDA approval in October 2019.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
